Hyperbaric Oxygen Treatment (HBOT) Study:
Jamesy is one of the first children with Duchenne Muscular Dystrophy to undergo HBOT treatment. Through this study, his marked improvements have led to the first ever hyperbaric pre-clinical trial to be hosted by the University of Minnesota. The launch of the HBOT research is a primary focus of our current fundraising efforts. The findings may provide the vital information needed to prove the clinical efficacy of oxygen therapy, and could lay the groundwork to make this treatment available to all children suffering from Duchenne.
The goal of the HBOT study is to enable these children to walk for as long as possible, until a cure can be found.